Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems.

ABSTRACT:

Background

Each year, influenza is responsible for hundreds of thousand cases of illness and deaths worldwide. Due to the virus' fast mutation rate, the World Health Organization (WHO) is constantly on alert to rapidly respond to emerging pandemic strains. Although anti-viral therapies exist, the most proficient way to stop the spread of disease is through vaccination. The majority of influenza vaccines on the market are produced in embryonic hen's eggs and are composed of purified viral antigens from inactivated whole virus. This manufacturing system, however, is limited in its production capacity. Cell culture produced vaccines have been proposed for their potential to overcome the problems associated with egg-based production. Virus-like particles (VLPs) of influenza virus are p

SUBMITTER: Thompson CM 

PROVIDER: S-EPMC4432999 | biostudies-literature | 2015 May

REPOSITORIES: biostudies-literature